Home Biosimilar Antibodies Neuronal Signaling CGRP Receptor antibody Fremanezumab (Anti-CALCA / CGRP) For research use only.
Not for use in humans.

Fremanezumab (Anti-CALCA / CGRP)

Synonyms: TEV-48125

Fremanezumab (Anti-CALCA / CGRP) is a humanized IgG2a monoclonal antibody that selectively and potently targets calcitonin gene-related peptide (CGRP). Fremanezumab has the potential for chronic migraine research.. MW: 145.5 kD.

Fremanezumab (Anti-CALCA / CGRP)

Purity & Quality Control

≥99

Choose Selective CGRP Receptor Inhibitors

Biological Activity

Description Fremanezumab (Anti-CALCA / CGRP) is a humanized IgG2a monoclonal antibody that selectively and potently targets calcitonin gene-related peptide (CGRP). Fremanezumab has the potential for chronic migraine research.. MW: 145.5 kD.

Product Details

CAS No. 1655501-53-3
Molecular Weight 145.5
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Fremanezumab (Anti-CALCA / CGRP) | Fremanezumab (Anti-CALCA / CGRP) supplier | purchase Fremanezumab (Anti-CALCA / CGRP) | Fremanezumab (Anti-CALCA / CGRP) cost | Fremanezumab (Anti-CALCA / CGRP) manufacturer | order Fremanezumab (Anti-CALCA / CGRP) | Fremanezumab (Anti-CALCA / CGRP) distributor